scholarly journals Mast Cell-Deficient KitW-shMice Develop House Dust Mite-Induced Lung Inflammation despite Impaired Eosinophil Recruitment

2014 ◽  
Vol 6 (2) ◽  
pp. 219-226 ◽  
Author(s):  
J. Daan de Boer ◽  
Jack Yang ◽  
Florry E. van den Boogaard ◽  
Arie J. Hoogendijk ◽  
Regina de Beer ◽  
...  
Allergy ◽  
2021 ◽  
Author(s):  
Erika Mendez‐Enriquez ◽  
Perla Abigail Alvarado‐Vazquez ◽  
Willem Abma ◽  
Oscar E. Simonson ◽  
Sergey Rodin ◽  
...  

2010 ◽  
Vol 28 (7) ◽  
pp. 597-603 ◽  
Author(s):  
Li Hongjia ◽  
Gai Qingling ◽  
Lin Meiying ◽  
Wang Weixuan ◽  
Zhang Lihong ◽  
...  

Author(s):  
Erika Haide Mendez ◽  
Perla Abigail Alvarado Vazquez ◽  
Willem Abma ◽  
Oscar Simonson ◽  
Sergey Rodin ◽  
...  

2015 ◽  
Vol 309 (8) ◽  
pp. L768-L775 ◽  
Author(s):  
Johannes D. de Boer ◽  
Lea C. Berkhout ◽  
Sacha F. de Stoppelaar ◽  
Jack Yang ◽  
Roelof Ottenhoff ◽  
...  

Asthma is a chronic disease of the airways; asthma patients are hampered by recurrent symptoms of dyspnoea and wheezing caused by bronchial obstruction. Most asthma patients suffer from chronic allergic lung inflammation triggered by allergens such as house dust mite (HDM). Coagulation activation in the pulmonary compartment is currently recognized as a feature of allergic lung inflammation, and data suggest that coagulation proteases further drive inflammatory mechanisms. Here, we tested whether treatment with the oral thrombin inhibitor dabigatran attenuates allergic lung inflammation in a recently developed HDM-based murine asthma model. Mice were fed dabigatran (10 mg/g) or placebo chow during a 3-wk HDM airway exposure model. Dabigatran treatment caused systemic thrombin inhibitory activity corresponding with dabigatran levels reported in human trials. Surprisingly, dabigatran did not lead to inhibition of HDM-evoked coagulation activation in the lung as measured by levels of thrombin-antithrombin complexes and D-dimer. Repeated HDM administration caused an influx of eosinophils and neutrophils into the lungs, mucus production in the airways, and a T helper 2 response, as reflected by a rise in bronchoalveolar IL-4 and IL-5 levels and a systemic rise in IgE and HDM-IgG1. Dabigatran modestly improved HDM-induced lung pathology ( P < 0.05) and decreased IL-4 levels ( P < 0.01), without influencing other HDM-induced responses. Considering the limited effects of dabigatran in spite of adequate plasma levels, these results argue against clinical evaluation of dabigatran in patients with asthma.


PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e112589 ◽  
Author(s):  
Ling Chen ◽  
Kara L. Perks ◽  
Stephen M. Stick ◽  
Anthony Kicic ◽  
Alexander N. Larcombe ◽  
...  

2018 ◽  
Vol 70 (2) ◽  
pp. 228-241.e5 ◽  
Author(s):  
Yu-Ping Lin ◽  
Charmaine Nelson ◽  
Holger Kramer ◽  
Anant B. Parekh

2015 ◽  
Vol 45 (4) ◽  
pp. 1116-1128 ◽  
Author(s):  
Katie E. Burrows ◽  
Celine Dumont ◽  
Clare L. Thompson ◽  
Matthew C. Catley ◽  
Kate L. Dixon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document